Patents by Inventor Marion C. Lanier

Marion C. Lanier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRF receptor antagonists and methods relating thereto
    Publication number: 20040266799
    Abstract: CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke.
    Type: Application
    Filed: April 22, 2004
    Publication date: December 30, 2004
    Applicant: Neurocrine Biosciences, Inc.
    Inventors: Mustapha Haddach, Marion C. Lanier, Charles Q. Huang, James R. McCarthy
  • CRF receptor antagonists and methods relating thereto
    Patent number: 6747034
    Abstract: CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke.
    Type: Grant
    Filed: November 2, 2001
    Date of Patent: June 8, 2004
    Assignee: Neurocrine Biosciences, Inc.
    Inventors: Mustapha Haddach, Marion C. Lanier, Charles Q. Huang, James R. McCarthy
  • Ligands of melanocortin receptors and compositions and methods related thereto
    Publication number: 20040053933
    Abstract: Compounds which function as melanocortin receptor ligands and having utility in the treatment of melanocortin receptor-based disorders.
    Type: Application
    Filed: May 9, 2003
    Publication date: March 18, 2004
    Applicant: Neurocrine Biosciences, Inc.
    Inventors: Joseph Pontillo, Dragan Marinkovic, Marion C. Lanier, Joe Anh Tran, Melissa Arellano, Jessica Parker, Jodie Nelson, Chen Chen, Fabio C. Tucci, Caroline Chen, Wanlong Jiang, Nicole White
  • CRF receptor antagonists and methods relating thereto
    Publication number: 20020151557
    Abstract: CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke.
    Type: Application
    Filed: November 2, 2001
    Publication date: October 17, 2002
    Applicant: Neurocrine Biosciences, Inc
    Inventors: Mustapha Haddach, Marion C. Lanier, Charles Q. Huang, James R. McCarthy